Effects of Pilates and Moderate-Intensity Aerobic Exercise on Postpartum Weight Loss and Body Composition
Effects of Pilates Versus Moderate Intensity Aerobic Exercises on Weight Loss, Body Mass Index and Waist to Hip Ratio in Postpartum Period.
調査の概要
詳細な説明
After childbirth, many women find it hard to lose the extra weight they gained during pregnancy. This weight can affect their health, self-esteem, and ability to stay active. Regular exercise is a safe and natural way to help lose weight and improve fitness during the postpartum period. Two popular forms of exercise are Pilates and moderate-intensity aerobic exercises (like brisk walking or cycling).
This study aims to find out which type of exercise-Pilates or aerobic exercise- is more helpful for postpartum women in reducing body weight, Body Mass Index (BMI), and waist-to-hip ratio over a period of 8 weeks. To do this, women will be randomly divided into two groups. One group will do Pilates exercises, and the other group will do aerobic exercises. Both groups will exercise three times a week for about 45-60 minutes each session. At the end of 8 weeks, the results will be compared to see which type of exercise is more effective.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Imran Amjad, PHD*
- 電話番号:03324390125
- メール:imran.amjad@riphah.edu.pk
研究連絡先のバックアップ
- 名前:Imran Amjad, PHD*
- 電話番号:0515481826
- メール:imran.amjad@riphah.edu.pk
研究場所
-
-
Punjab Province
-
Lahore、Punjab Province、パキスタン、54000
- 募集
- Ghurki Teaching Hospital
-
コンタクト:
- Ghulam Fatima, PhD*
- 電話番号:03034073057
- メール:ghulam.fatima@riphah.edu.pk
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Women aged 20 to 40 years
- BMI > 25kg/m2 at baseline
- Medically cleared by a health professional to perform physical activity
- Women 6 to 24 weeks postpartum
Exclusion Criteria:
- Women with complications during delivery (Cesarean complications, perineal tears grade 3 or 4)
- Presence of chronic disorders (diabetes mellitus, cardiovascular disorders, severe anemia)
- Neuromusculoskeletal disorders affecting physical activity
- Currently participating in another fitness program
- Postpartum depression or other psychological disorders that may affect adherence
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Group A - Pilates Group
Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening
|
Pilates Group Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening.
Structure: Warm-up (10 mins): Light mobility and breathing exercises; Main Session (30-40 mins): Pelvic tilts, bridging, leg stretches, roll-ups, side-lying series; Focus on posture, controlled movement, and core engagement; Cool-down (5-10 mins): Gentle stretching and relaxation.
Progression: Gradual increase in intensity and complexity over 8 weeks.
Supervision: Sessions led by a trained physiotherapist or certified Pilates instructor.
|
|
アクティブコンパレータ:Group B - Aerobic Exercise Group
Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines) Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale)
|
Aerobic Exercise Group Type of Exercise: Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines).
Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale).
Structure: Warm-up (10 mins): Marching in place, arm circles, step touch; Main Session (30-40 mins): Rhythmic aerobic routines or treadmill walking; Cool-down (5-10 mins): Stretching major muscle groups.
Supervision: Sessions conducted under the guidance of a physiotherapist or fitness instructor.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Weight (kilograms) - measured using a calibrated weighing scale
時間枠:8 weeks
|
Measured with a calibrated digital weighing scale.
Participants will be weighed barefoot, wearing light clothing, after emptying their bladder.
Reliable if calibrated regularly and used under standardized conditions (same scale, same time of day, light clothing, after voiding).
Test-retest reliability > 0.97.
Highly valid for measuring body weight; directly measures mass in kilogram.
The scale's accuracy is typically within 0.1 kg.
|
8 weeks
|
|
Body Mass Index (BMI)
時間枠:8 weeks
|
Calculated by dividing weight (kg) by the square of height (m) (BMI = weight/height²).
Height will be measured once at baseline with a stadiometer.
Reliable when the procedure is standardized (barefoot, standing straight, head in Frankfort plane).
Intra-observer reliability > 0.95.
Valid anthropometric tool; stadiometers accurately reflect true stature when calibrated.
|
8 weeks
|
|
Waist to Hip Ratio (WHR)
時間枠:8 weeks
|
Calculated by dividing Waist by Hip (WHR = Waist cm / Hip cm).
Reliable if both waist and hip are measured accurately with the same procedure.
WHR is a well validated indicator of body-fat distribution and health-risk; a higher WHR is strongly associated with metabolic disorders
|
8 weeks
|
協力者と研究者
捜査官
- 主任研究者:Zainab Nadeem, MS*、Riphah International University
出版物と役立つリンク
一般刊行物
- Seitz D, Hintze A. [Myelomalacia following vertebral angiography with a femoral catheter (author's transl)]. Rofo. 1976 Jul;125(1):59-62. doi: 10.1055/s-0029-1230418. German.
- Goldstein J. Biologic and clinical considerations of hepatitis B infection. J Endod. 1979 Feb;5(2):56-9. doi: 10.1016/S0099-2399(79)80108-9. No abstract available.
- Drake AF, Dufton MJ, Hider RC. The flexible nature of a critical peptide region common to all Elapidae "short" neurotoxins. FEBS Lett. 1977 Nov 15;83(2):202-6. doi: 10.1016/0014-5793(77)81005-3. No abstract available.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- REC/RCR & AHS/25/0527
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。